Improved Blood Pressure: Weight reduction and GLP-1s direct cardiovascular effects can lead to lower blood pressure
Lilly initiated a Phase 3 trial in 2025 for a GLP-1/GIP receptor agonist as a treatment for alcoholism
Tirzepatide (Mounjaro, Zepbound) Tirzepatide activates both GLP-1 and GIP receptors, providing stronger weight loss effects than semaglutide in head-to-head trials
Alcohol and tobacco consumption for both comparisons were sourced from Portugal-specific data for the general population, as these data were not collected in the PIONEER 2 or 3 clinical trials [26, 27]
Its soft, lightly spiced, and easy to portion, which makes it a good choice when you want something warm and familiar but dont feel like eating a full plate
Side effects The most common side effects of GLP-1 medications are gastrointestinal, and theyre directly tied to how the drugs work